secwatch.observer — SEC 8-K summary
======================================

Issuer:     Camp4 Therapeutics Corp (CAMP)
CIK:        0001736730
Form:       8-K
Filed at:   2026-01-09T23:59:59+00:00
Accession:  0001736730-26-000004
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CAMP4 Therapeutics updates corporate presentation; no specific material changes disclosed
--------------------------------------------------------------------------------

- Company furnished an updated corporate presentation as Exhibit 99.1.
- Presentation is available on the Investors section of the company's website.
- No financial results, pipeline milestones, or guidance changes announced in the filing.
- The 8-K is a routine Regulation FD disclosure with no new material information.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1736730/000173673026000004/0001736730-26-000004-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1736730/000173673026000004/camp-20260109.htm
  HTML page:      https://secwatch.observer/filing/0001736730-26-000004

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer